Cumulative metabolic score for insulin resistance and heart failure risk: A prospective study
Nutrition, Metabolism and Cardiovascular Diseases · 2026-07 · 36 (7) · 104634
DOI: 10.1016/j.numecd.2026.104634 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026-07. Verfasst von Zuxu Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, North China University of Science and Technology, Tangshan, China. Hauptthemen laut MEDLINE: Heart Failure, Insulin Resistance, Metabolic Syndrome, Blood Glucose. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND AND AIM: The Metabolic Score for Insulin Resistance (METS-IR) is recognized as an indicator associated with the risk of Heart Failure (HF). However, evidence regarding its long-term impact is limited. This study aimed to evaluate the association between cumulative METS-IR (cumMETS-IR) and the risk of incident HF. METHODS AND RESULTS: We performed a prospective cohort analysis involving 51,155 participants from the Kailuan Study who underwent three health examinations (2006-2010) and were followed for incident HF until December 31, 2022. CumMETS-IR was calculated and analyzed using Cox proportional hazards models. Over a median follow-up of 12 years, higher cumMETS-IR was strongly and progressively associated with an increased risk of HF. Participants in the highest quartile had a 59% higher risk than those in the lowest. The incidence density of HF per 1000 person-years increased progressively across quartiles: Q1: 0.90 (0.76-1.07), Q2: 1.61 (1.41-1.83), Q3: 2.38 (2.14-2.64), and Q4: 3.60 (3.30-3.93). Maintaining high exposure for 2, 4, and 6 years increased risk by 23%, 49%, and 57%, respectively. Notably, these associations were significantly stronger in males and in adults aged ≥60 years. Adding cumMETS-IR to a conventional risk model also improved the prediction of HF. CONCLUSION: Higher levels of cumMETS-IR are associated with an increased risk of HF, particularly pronounced in males and older adults. Long-term monitoring of METS-IR may facilitate the early identification of high-risk individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, North China University of Science and Technology, Tangshan, China.
- Department of Cardiology, Kailuan General Hospital, Tangshan, China.
- Department of Neurosurgery, Affiliated Hospital of North China University of Science and Technology, Tangshan, China.
- School of Public Health, North China University of Science and Technology, Tangshan, China. Electronic address: tswydd@sina.com.
- Department of Cardiology, Kailuan General Hospital, Tangshan, China. Electronic address: csh01062011@163.com.
- School of Public Health, North China University of Science and Technology, Tangshan, China; Tangshan Key Laboratory of Clinical Epidemiology, China; Hebei Coordinated Innovation Centre of Occupational Health and Safety,…
Zitieren
APA
Lin, Z., Wu, Y., Zhao, D., Kang, S., Zhang, M., Yang, P., Wu, Y., Chen, S., & Li, Y. (2026). Cumulative metabolic score for insulin resistance and heart failure risk: A prospective study. Nutrition, Metabolism and Cardiovascular Diseases, 36(7), 104634. https://doi.org/10.1016/j.numecd.2026.104634
Vancouver
Lin Z, Wu Y, Zhao D, Kang S, Zhang M, Yang P, et al. Cumulative metabolic score for insulin resistance and heart failure risk: A prospective study. Nutrition, Metabolism and Cardiovascular Diseases. 2026;36(7):104634. doi:10.1016/j.numecd.2026.104634
BibTeX
@article{Lin2026,
author = {Lin, Zuxu and Wu, Yuntao and Zhao, Dandan and Kang, Shiwei and Zhang, Mengcan and Yang, Peng and Wu, Ying and Chen, Shuohua and Li, Yun},
title = {Cumulative metabolic score for insulin resistance and heart failure risk: A prospective study},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2026},
volume = {36},
number = {7},
pages = {104634},
doi = {10.1016/j.numecd.2026.104634}
}
EUVIMED